Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster

Detalhes bibliográficos
Autor(a) principal: Oliveira, Igor Gomes de
Data de Publicação: 2011
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFG
Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tede/4263
Resumo: Clinical studies have shown that the combinations of chemotherapeutic drugs gemcitabine (GEM) plus cisplatin (CIS) and gemcitabine (GEM) plus doxorubicin (DXR) exert important cytotoxic activity against several types of cancer in advanced stages as well as metastatic cancer. CIS, DXR and GEM have different mechanisms of action. GEM is a pro-drug that must be phosphorylated by deoxycytidine kinase to evolve into its active form. Both gemcitabine diphosphate and gemcitabine triphosphate inhibit processes required for DNA synthesis. CIS induces a variety of DNA structural changes, mainly intra- and interstrand cross-links between adjacent purine bases. DXR acts as a topoisomerase II inhibitor. This study compares the genetic toxicity effects induced by GEM+CIS and GEM+DXR co-treatments with the single drug treatments. We used the Somatic Mutation And Recombination Test (SMART), which simultaneously detects and quantifies mutagenic and recombinogenic toxicological endpoints through loss of heterozygosity of two genetic markers involved in the metabolic pathways of the Drosophila melanogaster wing hairs formation. Using the standard cross, the third-stage larvae were chronically treated with different concentrations of GEM (0.008, 0.010, 0.012 and 0.014 mM) combined with CIS (0.05 mM) or DXR (0.2 mM). Comparing with GEM single treatment, GEM+CIS and GEM+DXR co-treatments induced a synergistic effect manifested as an increment in the mutant clones frequencies. Homologous recombination was the main genotoxic effect observed.
id UFG-2_4ba29fa5ac6f8041e3ae226272b68ae0
oai_identifier_str oai:repositorio.bc.ufg.br:tede/4263
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
repository_id_str
spelling Cunha, Kênya Silvahttp://lattes.cnpq.br/6124135410387685http://lattes.cnpq.br/2166272642011280Oliveira, Igor Gomes de2015-03-06T19:26:27Z2011-03-27OLIVEIRA, Igor Gomes de. Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster. 2011. 75 f. Dissertação (Mestrado em Biologia)–Universidade Federal de Goiás, Goiânia, 2011.http://repositorio.bc.ufg.br/tede/handle/tede/4263ark:/38995/0013000005qrrClinical studies have shown that the combinations of chemotherapeutic drugs gemcitabine (GEM) plus cisplatin (CIS) and gemcitabine (GEM) plus doxorubicin (DXR) exert important cytotoxic activity against several types of cancer in advanced stages as well as metastatic cancer. CIS, DXR and GEM have different mechanisms of action. GEM is a pro-drug that must be phosphorylated by deoxycytidine kinase to evolve into its active form. Both gemcitabine diphosphate and gemcitabine triphosphate inhibit processes required for DNA synthesis. CIS induces a variety of DNA structural changes, mainly intra- and interstrand cross-links between adjacent purine bases. DXR acts as a topoisomerase II inhibitor. This study compares the genetic toxicity effects induced by GEM+CIS and GEM+DXR co-treatments with the single drug treatments. We used the Somatic Mutation And Recombination Test (SMART), which simultaneously detects and quantifies mutagenic and recombinogenic toxicological endpoints through loss of heterozygosity of two genetic markers involved in the metabolic pathways of the Drosophila melanogaster wing hairs formation. Using the standard cross, the third-stage larvae were chronically treated with different concentrations of GEM (0.008, 0.010, 0.012 and 0.014 mM) combined with CIS (0.05 mM) or DXR (0.2 mM). Comparing with GEM single treatment, GEM+CIS and GEM+DXR co-treatments induced a synergistic effect manifested as an increment in the mutant clones frequencies. Homologous recombination was the main genotoxic effect observed.As combinações dos quimioterápicos gemcitabina (GEM) com cisplatina (CIS) e gemcitabina (GEM) com doxorrubicina (DXR) têm demonstrado uma importante atividade citotóxica contra vários tipos de câncer em estágio avançado e/ou metastático em diversos estudos clínicos. CIS, DXR e GEM possuem diferentes mecanismos de ação, sendo este um fator importante para o sucesso da associação entre quimioterápicos. A GEM é uma pró-droga análoga de desoxicitidina que deve ser fosforilada pela desoxicitidina quinase para se tornar ativa. Ambos, gemcitabina difosfato e gemcitabina trifosfato, atuam inibindo os processos necessários para a síntese de DNA. Já a CIS induz uma variedade de mudanças estruturais, principalmente por meio de ligações cruzadas intra e intercadeias entre bases purínicas adjacentes do DNA. A DXR age como um inibidor da topoisomerase II, formando um complexo entre esta proteína e o DNA, inibindo os processos necessários para a síntese do DNA. Este estudo teve como objetivo comparar os efeitos de toxicidade genética induzidos pelos tratamentos utilizando os combinados de GEM+CIS e GEM+DXR com os tratamentos usando as drogas isoladas. Utilizamos o Teste de Mutação e Recombinação Somática (SMART), que detecta e quantifica, simultaneamente, parâmetros mutagênicos e recombinogênicos através da perda de heterozigose de dois marcadores genéticos envolvidos nas vias metabólicas da formação dos pêlos da asa de Drosophila melanogaster. Usando o cruzamento padrão, as larvas de terceiro estágio foram tratadas cronicamente com diferentes concentrações de GEM (0,008, 0,010, 0,012 e 0,014 mM), combinado com CIS (0,05 mM) ou DXR (0,2 mM). Comparando os combinados GEM+CIS e GEM+DXR com o tratamento isolado com GEM, notou-se que nos combinados houve um efeito sinérgico demonstrado pelo aumento nas frequências de clones mutantes destes em comparação com o tratamento isolado com GEM. A recombinação homóloga foi o principal tipo de efeito genotóxico observado nas combinações.Submitted by Luanna Matias (lua_matias@yahoo.com.br) on 2015-03-06T19:20:01Z No. of bitstreams: 2 Dissertação - Igor Gomes de Oliveira - 2011.pdf: 1076733 bytes, checksum: 1faa803ec01cef7512bec500010c985b (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Approved for entry into archive by Luanna Matias (lua_matias@yahoo.com.br) on 2015-03-06T19:26:27Z (GMT) No. of bitstreams: 2 Dissertação - Igor Gomes de Oliveira - 2011.pdf: 1076733 bytes, checksum: 1faa803ec01cef7512bec500010c985b (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Made available in DSpace on 2015-03-06T19:26:27Z (GMT). No. of bitstreams: 2 Dissertação - Igor Gomes de Oliveira - 2011.pdf: 1076733 bytes, checksum: 1faa803ec01cef7512bec500010c985b (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2011-03-27Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPqapplication/pdfhttp://repositorio.bc.ufg.br/tede/retrieve/17568/Disserta%c3%a7%c3%a3o%20-%20Igor%20Gomes%20de%20Oliveira%20-%202011.pdf.jpgporUniversidade Federal de GoiásPrograma de Pós-graduação em Biologia (ICB)UFGBrasilInstituto de Ciências Biológicas - ICB (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessQuimioterápicosMutagêneseDrosophila melanogasterChemotherapyMutagensisDrosophila melanogasterCIENCIAS BIOLOGICAS::BIOLOGIA GERALInvestigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogasterInvestigation of mutagenic and recombinogenic combination of gemcitabine + cisplatin and gemcitabine + doxorubicin in somatic cells of Drosophila melanogasterinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis6883982777473437920600600600600-3872772117827373404-1634559385931244697-2555911436985713659reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGTEXTDissertação - Igor Gomes de Oliveira - 2011.pdf.txtDissertação - Igor Gomes de Oliveira - 2011.pdf.txtExtracted Texttext/plain125739http://repositorio.bc.ufg.br/tede/bitstreams/1a07f9ea-ccc6-49c0-b4af-aede5545df24/download0b5d5938b3277d579063a1641da0a5c3MD56THUMBNAILDissertação - Igor Gomes de Oliveira - 2011.pdf.jpgDissertação - Igor Gomes de Oliveira - 2011.pdf.jpgGenerated Thumbnailimage/jpeg2161http://repositorio.bc.ufg.br/tede/bitstreams/a10fc0f0-ddf8-4013-b31b-e8aca0ef4100/download4d6ce0d31eddbda07c6920231084a73dMD57LICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/5aaf0f9c-899c-42d5-aa64-a018f9aee2e6/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/8cdca6d7-a4fe-4144-9e4b-afb376573775/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-822376http://repositorio.bc.ufg.br/tede/bitstreams/430d6994-1b4a-4d49-a130-a3c334ccdc14/downloadb292a83e42bd8ad62533bba1395b83ffMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-823148http://repositorio.bc.ufg.br/tede/bitstreams/411db71e-9396-4955-93e9-57c0307e778b/download9da0b6dfac957114c6a7714714b86306MD54ORIGINALDissertação - Igor Gomes de Oliveira - 2011.pdfDissertação - Igor Gomes de Oliveira - 2011.pdfapplication/pdf1076733http://repositorio.bc.ufg.br/tede/bitstreams/cb3512fc-032c-43e3-882d-d34e3c2e7114/download1faa803ec01cef7512bec500010c985bMD55tede/42632015-03-07 03:02:05.998http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/4263http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2015-03-07T06:02:05Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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
dc.title.eng.fl_str_mv Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster
dc.title.alternative.eng.fl_str_mv Investigation of mutagenic and recombinogenic combination of gemcitabine + cisplatin and gemcitabine + doxorubicin in somatic cells of Drosophila melanogaster
title Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster
spellingShingle Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster
Oliveira, Igor Gomes de
Quimioterápicos
Mutagênese
Drosophila melanogaster
Chemotherapy
Mutagensis
Drosophila melanogaster
CIENCIAS BIOLOGICAS::BIOLOGIA GERAL
title_short Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster
title_full Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster
title_fullStr Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster
title_full_unstemmed Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster
title_sort Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster
author Oliveira, Igor Gomes de
author_facet Oliveira, Igor Gomes de
author_role author
dc.contributor.advisor1.fl_str_mv Cunha, Kênya Silva
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/6124135410387685
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/2166272642011280
dc.contributor.author.fl_str_mv Oliveira, Igor Gomes de
contributor_str_mv Cunha, Kênya Silva
dc.subject.por.fl_str_mv Quimioterápicos
Mutagênese
Drosophila melanogaster
topic Quimioterápicos
Mutagênese
Drosophila melanogaster
Chemotherapy
Mutagensis
Drosophila melanogaster
CIENCIAS BIOLOGICAS::BIOLOGIA GERAL
dc.subject.eng.fl_str_mv Chemotherapy
Mutagensis
Drosophila melanogaster
dc.subject.cnpq.fl_str_mv CIENCIAS BIOLOGICAS::BIOLOGIA GERAL
description Clinical studies have shown that the combinations of chemotherapeutic drugs gemcitabine (GEM) plus cisplatin (CIS) and gemcitabine (GEM) plus doxorubicin (DXR) exert important cytotoxic activity against several types of cancer in advanced stages as well as metastatic cancer. CIS, DXR and GEM have different mechanisms of action. GEM is a pro-drug that must be phosphorylated by deoxycytidine kinase to evolve into its active form. Both gemcitabine diphosphate and gemcitabine triphosphate inhibit processes required for DNA synthesis. CIS induces a variety of DNA structural changes, mainly intra- and interstrand cross-links between adjacent purine bases. DXR acts as a topoisomerase II inhibitor. This study compares the genetic toxicity effects induced by GEM+CIS and GEM+DXR co-treatments with the single drug treatments. We used the Somatic Mutation And Recombination Test (SMART), which simultaneously detects and quantifies mutagenic and recombinogenic toxicological endpoints through loss of heterozygosity of two genetic markers involved in the metabolic pathways of the Drosophila melanogaster wing hairs formation. Using the standard cross, the third-stage larvae were chronically treated with different concentrations of GEM (0.008, 0.010, 0.012 and 0.014 mM) combined with CIS (0.05 mM) or DXR (0.2 mM). Comparing with GEM single treatment, GEM+CIS and GEM+DXR co-treatments induced a synergistic effect manifested as an increment in the mutant clones frequencies. Homologous recombination was the main genotoxic effect observed.
publishDate 2011
dc.date.issued.fl_str_mv 2011-03-27
dc.date.accessioned.fl_str_mv 2015-03-06T19:26:27Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv OLIVEIRA, Igor Gomes de. Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster. 2011. 75 f. Dissertação (Mestrado em Biologia)–Universidade Federal de Goiás, Goiânia, 2011.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tede/4263
dc.identifier.dark.fl_str_mv ark:/38995/0013000005qrr
identifier_str_mv OLIVEIRA, Igor Gomes de. Investigação do potencial mutagênico e recombinogênico dos combinados gemcitabina+doxorrubicina e gemcitabina+cisplatina em células somáticas de Drosophila melanogaster. 2011. 75 f. Dissertação (Mestrado em Biologia)–Universidade Federal de Goiás, Goiânia, 2011.
ark:/38995/0013000005qrr
url http://repositorio.bc.ufg.br/tede/handle/tede/4263
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv 6883982777473437920
dc.relation.confidence.fl_str_mv 600
600
600
600
dc.relation.department.fl_str_mv -3872772117827373404
dc.relation.cnpq.fl_str_mv -1634559385931244697
dc.relation.sponsorship.fl_str_mv -2555911436985713659
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Biologia (ICB)
dc.publisher.initials.fl_str_mv UFG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Instituto de Ciências Biológicas - ICB (RG)
publisher.none.fl_str_mv Universidade Federal de Goiás
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
instname_str Universidade Federal de Goiás (UFG)
instacron_str UFG
institution UFG
reponame_str Repositório Institucional da UFG
collection Repositório Institucional da UFG
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/1a07f9ea-ccc6-49c0-b4af-aede5545df24/download
http://repositorio.bc.ufg.br/tede/bitstreams/a10fc0f0-ddf8-4013-b31b-e8aca0ef4100/download
http://repositorio.bc.ufg.br/tede/bitstreams/5aaf0f9c-899c-42d5-aa64-a018f9aee2e6/download
http://repositorio.bc.ufg.br/tede/bitstreams/8cdca6d7-a4fe-4144-9e4b-afb376573775/download
http://repositorio.bc.ufg.br/tede/bitstreams/430d6994-1b4a-4d49-a130-a3c334ccdc14/download
http://repositorio.bc.ufg.br/tede/bitstreams/411db71e-9396-4955-93e9-57c0307e778b/download
http://repositorio.bc.ufg.br/tede/bitstreams/cb3512fc-032c-43e3-882d-d34e3c2e7114/download
bitstream.checksum.fl_str_mv 0b5d5938b3277d579063a1641da0a5c3
4d6ce0d31eddbda07c6920231084a73d
bd3efa91386c1718a7f26a329fdcb468
4afdbb8c545fd630ea7db775da747b2f
b292a83e42bd8ad62533bba1395b83ff
9da0b6dfac957114c6a7714714b86306
1faa803ec01cef7512bec500010c985b
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository.mail.fl_str_mv tasesdissertacoes.bc@ufg.br
_version_ 1811721405566287872